Publikationen in Zusammenarbeit mit Forschern von Institut d'Investigació Biomédica de Bellvitge (1)

2021

  1. Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48